Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)

Clinical trial NCT00441012 · COMPLETED

Trial details

NCT number: NCT00441012
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type B Hepatitis B

Start date: 2006-12-01
Primary completion: 2008-06-01
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.